2025年1月1日 · Purpose: To evaluate the role of first-eye vault after the implantation of implantable collamer lens (ICL) V4c in selecting ICL size for the second eye and analyze the changing characteristics of the vault.

2024年11月30日 · In summary, research shows that patients with relatively shallow ACD have shown similar positive clinical outcomes and safety in the early and midterm postoperative periods following ICL implantation, as compared to patients with normal ACD.

(implantable collamer lens, ICL)植入术是眼内屈光手术的一种典型术式，对于中高度近视的患者，ICL 植 入术被认为是矫正中高度近视的最优选择。 大量临床研究证实，术后患者视觉质量及生活质量得到显著

2024年9月25日 · 在现代眼科手术中，有晶体眼人工晶体（ICL）植入术已成为矫正高度近视的有效方法。然而，手术后的拱高（vault）变化对手术效果和患者满意度有

This review summarizes the available literature and provides updates on the efficacy, safety, and patient outcomes of phakic intraocular lens implantation using implantable collamer lens (ICL), with a focus on newer models with a central port ...

2022年11月10日 · This study investigated the early outcomes of anterior segment parameters after implanting an implantable collamer lens with a central hole (ICL V4c) in patients with myopia and determined the earliest follow-up time for detecting potential complications.

2024年7月23日 · Given that over two million implantable collamer lenses (ICLs) have been implanted worldwide and that a percentage of these patients will develop early cataracts (a late complication of pIOL) and almost all will eventually develop age-related cataracts, it is crucial to understand the visual prognosis for these typically highly myopic patients a...

2024年9月25日 · Selecting the ICL size for the second eye based on the first eye's vault measurement 2 hours postoperatively can effectively minimize the need for further surgeries. Notably, eyes with a higher initial vault experienced a more pronounced decrease.

2024年10月31日 · Objective: To investigate the clinical effect and safety of Implantable Collamer Lens (ICL) implantation in myopic patients with relatively shallow anterior chamber depth (ACD). Methods: Retrospective analysis, comparative, non-interventional case series.

Postoperative central vaulting was 466+/-218 microm (range, 30-900 microm) in eyes treated with the V4 models and 321+/-200 microm (range, 150-900 microm) in those treated with early ICL models. From the 6-month follow-up onward, a continuous and nearly linear reduction of central vaulting was observed.